A potent antibiotic combination of beta-lactamase inhibitor Clavulanic Acid and third-generation cefixime, Revacef-CV Tablet is designed to efficiently treat a variety of bacterial infections. While cefixime inhibits bacterial growth, clavulanic acid increases its efficacy by halting bacterial resistance. Better efficacy is guaranteed by this dual-action formulation, particularly against resistant bacterial strains that cause infections of the skin, ears, throat, urinary tract, and respiratory tract.
